LGND - Ligand Pharmaceuticals Incorporated

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts4245
Avg. Estimate0.630.572.993.55
Low Estimate0.470.452.842.4
High Estimate0.740.73.084.05
Year Ago EPS1.71.167.152.99
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts4155
Avg. Estimate25.16M20.02M118.56M125.11M
Low Estimate24.42M20.02M117.7M121M
High Estimate26.09M20.02M119.37M129.4M
Year Ago Sales59.59M43.48M251.45M118.56M
Sales Growth (year/est)-57.80%-54.00%-52.90%5.50%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.1.221.020.550.61
EPS Actual1.71.160.680.49
Difference0.480.140.13-0.12
Surprise %39.30%13.70%23.60%-19.70%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate0.630.572.993.55
7 Days Ago0.760.683.253.81
30 Days Ago0.810.843.253.81
60 Days Ago0.790.813.223.71
90 Days Ago0.790.813.223.71
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A2
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1111
Growth EstimatesLGNDIndustrySectorS&P 500
Current Qtr.-62.90%N/AN/A0.02
Next Qtr.-50.90%N/AN/A0.06
Current Year-58.20%N/AN/A-0.03
Next Year18.70%N/AN/A0.14
Next 5 Years (per annum)-4.10%N/AN/A0.07
Past 5 Years (per annum)33.96%N/AN/AN/A